The treatment of hairy cell leukemia with recombinant alfa interferon: a multi-institutional study
β Scribed by John A. Thompson; Alexander Fefer
- Publisher
- Springer US
- Year
- 1987
- Tongue
- English
- Weight
- 286 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
β¦ Synopsis
This report expands on previous work with interferon alfa-2b (Intron A; Schering-Plough) in the treatment of hairy cell leukemia (HCL). Sixty-four patients were treated, with 89% achieving a response (either CR, PR or MR). The percentage of hairy cells in the peripheral blood decreased dramatically within one month and in the marrow, progressively over nine months. Normalization of blood counts was associated with a marked decline in serious infections and in the need for red cell or platelet transfusions. Preliminary results with a further group of patients confirm these satisfactory results.
π SIMILAR VOLUMES
## Background: Deoxycoformycin (dcf) has been reported to produce high response rates in patients with hairy cell leukemia (hcl), but to the authors' knowledge data regarding experience with such therapy in a large hcl series are scarce. ## Methods: Between 1988-1997, dcf (4 mg/m(2)/day, every 2
The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-β£) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l